Literature DB >> 23722987

Local health department public vaccination clinic success during 2009 pH1N1.

Tamar Klaiman1, Katherine Oʼconnell, Michael Stoto.   

Abstract

CONTEXT: Local health departments (LHDs) were responsible for administering vaccine to the public during the 2009 H1N1 campaign but had relatively little guidance or experience to inform such a large campaign with limited vaccine supply. They used various processes to deliver vaccines to the public. Learning from the LHDs that were successful in their public vaccination campaigns can help inform future vaccination efforts.
OBJECTIVE: To learn from H1N1 campaign in order to improve responses to similar events in the future. We used a positive deviance approach to identify positive outlier LHDs during the 2009 H1N1 vaccination campaigns. We then used realist evaluation to learn about the combinations of context and mechanisms that led select LHDs to perform well.
DESIGN: This project was a retrospective qualitative study. We used process mapping to define the steps involved in implementing public vaccination clinics. We identified positive outliers in H1N1 public vaccination efforts and conducted in-depth interviews with LHD staff to learn about the context and mechanisms that led to successful public vaccination clinics. PARTICIPANTS: This study focused on positive outliers in LHD vaccination efforts during the 2009 H1N1 campaign that implemented public vaccination clinics. MAIN OUTCOME MEASURE(S): Study outcomes focused on the combinations of context and mechanisms that led to successful outcomes in high-performing LHDs. Specific context + mechanism = outcomes stories are reported.
RESULTS: We found that successful LHDs defined priority groups, communicated with the public, maintained adequate staffing, established community partnerships, and maintained flexibility. We describe the specific contexts that triggered key mechanisms, which, when combined, led to successful outcomes.
CONCLUSIONS: The positive deviance and realist evaluation approach allowed us to understand how LHD context triggered specific mechanisms, which led to successful public clinics. The experience of successful LHDs can assist similar LHDs in implementing successful public vaccination clinics in the future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23722987     DOI: 10.1097/PHH.0b013e318269e434

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  5 in total

1.  Opening government health data to the public: benefits, challenges, and lessons learned from early innovators.

Authors:  Erika G Martin; Grace M Begany
Journal:  J Am Med Inform Assoc       Date:  2017-03-01       Impact factor: 4.497

Review 2.  Positive deviance in health and medical research on individual level outcomes - a review of methodology.

Authors:  Byron A Foster; Kylie Seeley; Melinda Davis; Janne Boone-Heinonen
Journal:  Ann Epidemiol       Date:  2021-12-14       Impact factor: 6.996

3.  Establishment and evaluation of scalable COVID-19 vaccine clinics at a large university.

Authors:  Gretchen K Garofoli; Marina Gálvez-Peralta; Ashleigh L Barrickman; Angela L Goodhart; Heather Johnson; Ashlee N McMillan; Betsy M Elswick; Erin S Newmeyer; Carmen N Burrell; Krista D Capehart; William P Petros
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-31

4.  What does high and low have to do with it? Performance classification to identify health system factors associated with effective prevention of mother-to-child transmission of HIV delivery in Mozambique.

Authors:  Sarah Gimbel; Joachim Voss; Alison Rustagi; Mary Anne Mercer; Brenda Zierler; Stephen Gloyd; Maria de Joana Coutinho; Maria de Fatima Cuembelo; Kenneth Sherr
Journal:  J Int AIDS Soc       Date:  2014-03-24       Impact factor: 5.396

Review 5.  What methods are used to apply positive deviance within healthcare organisations? A systematic review.

Authors:  Ruth Baxter; Natalie Taylor; Ian Kellar; Rebecca Lawton
Journal:  BMJ Qual Saf       Date:  2015-11-20       Impact factor: 7.035

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.